Candesartan could ameliorate the COVID-19 cytokine storm
Background: Angiotensin receptor blockers (ARBs) reducing inflammation and protecting lung and brain function, could be of therapeutic efficacy in COVID-19 patients. Methods: Using GSEA, we compared our previous transcriptome analysis of neurons injured by glutamate and treated with the ARB Candesar...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13616
- Acceso en línea:
- https://doi.org/10.1016/j.biopha.2020.110653
http://hdl.handle.net/20.500.12010/13616
- Palabra clave:
- COVID-19
SARS-CoV-2
Immunity
Inflammation
NF-κB
Cytokine storm
Interferon
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Angiotensin receptor blockers
- Rights
- License
- Abierto (Texto Completo)